CSI Market
Sign In | Register

Orion Biotech Opportunities (ORIA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ORIA Annual Balance Sheets →
A period-by-period view of the balance sheet from Orion Biotech Opportunities to Dec 31 2021 helps clarify how Dec 31 2022's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.27
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.17
Total Current Assets0.44
Other Assets, Noncurrent202.89
Total Assets203.33
Liabilities
Accounts Payable, Current AC0.01
Accrued Liabilities, Current AC0.06
Financial Instruments0.00
Other Liabilities, Current0.00
Total Current Liabilities0.07
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE1.26
Deferred Compensation Liability, Classified, Noncurrent LI7.00
Total Liabilities8.33
Stockholders' Equity
Common Stock Value One0.00
Retained Earnings / Accumulated Deficit-7.79
Other Equity-202.79
Common Stockholder's Equity-210.59
Non-controlling interests & other202.79
Total Stockholder's Equity-7.79
Liabilities & Stockholder's Equity203.33
4 historic quarters locked

Sign in to unlock the full Orion Biotech Opportunities balance sheet history.

Sign In Create Free Account

About Orion Biotech Opportunities Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-23-024075

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.